By comparing these parameters between patients with SLE and healthy controls, this study seeks to elucidate the potential roles of EPAS-1 and ghrelin in the cardiac manifestations of SLE and their utility as biomarkers for disease severity and cardiac involvement. Here, EPAS1 is linked to systemic lupus erythematosus.